IAG Wealth Partners
ABBV icon

IAG Wealth Partners’s AbbVie ABBV Stock Holding History

IAG Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$197K Buy
752
+3
+0.4% +$769 0.02% 130
2026
Q2 		$189K Buy
749
+3
+0.4% +$645 0.02% 129
2026
Q1 		$162K Buy
746
+15
+2% +$3.33K 0.02% 132
2025
Q4 		$167K Buy
731
+3
+0.4% +$683 0.02% 126
2025
Q3 		$169K Sell
728
-421
-37% -$85.7K 0.02% 127
2025
Q2 		$213K Buy
1,149
+4
+0.3% +$743 0.03% 111
2025
Q1 		$240K Sell
1,145
-20
-2% -$3.89K 0.04% 99
2024
Q4 		$207K Sell
1,165
-104
-8% -$19.1K 0.04% 98
2024
Q3 		$251K Buy
1,269
+173
+16% +$32.3K 0.05% 90
2024
Q2 		$188K Sell
1,096
-67
-6% -$11.1K 0.04% 95
2024
Q1 		$212K Buy
1,163
+425
+58% +$73.2K 0.05% 90
2023
Q4 		$114K Sell
738
-73
-9% -$10.6K 0.03% 106
2023
Q3 		$121K Buy
811
+42
+5% +$6.17K 0.03% 98
2023
Q2 		$104K Buy
769
+3
+0.4% +$440 0.03% 113
2023
Q1 		$122K Sell
766
-33
-4% -$5.04K 0.03% 94
2022
Q4 		$129K Sell
799
-42
-5% -$6.44K 0.04% 87
2022
Q3 		$113K Buy
841
+85
+11% +$12.2K 0.04% 85
2022
Q2 		$116K Buy
756
+25
+3% +$3.82K 0.04% 83
2022
Q1 		$118K Buy
731
+41
+6% +$5.96K 0.04% 85
2021
Q4 		$93K Buy
690
+3
+0.4% +$354 0.03% 89
2021
Q3 		$75K Buy
687
+102
+17% +$11.7K 0.03% 95
2021
Q2 		$66K Buy
585
+103
+21% +$11.6K 0.02% 102
2021
Q1 		$53K Buy
482
+2
+0.4% +$214 0.02% 107
2020
Q4 		$52K Buy
480
+2
+0.4% +$192 0.02% 107
2020
Q3 		$42K Buy
478
+186
+64% +$17.5K 0.02% 110
2020
Q2 		$29K Sell
292
-9
-3% -$792 0.01% 131
2020
Q1 		$23K Buy
301
+2
+0.7% +$170 0.02% 134
2019
Q4 		$27K Buy
+299
New +$24.8K 0.02% 153

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

IAG Wealth Partners's ABBV Position: Q3 2026 in Review

IAG Wealth Partners increased its AbbVie (ABBV) stake by 0.4% in Q3 2026, buying an estimated $769 and bringing the position to 752 shares worth $197K. The position accounts for 0.02% of the portfolio, ranked #130.

IAG Wealth Partners first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. The position peaked at $251K in Q3 2024. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • IAG Wealth Partners held 752 shares of AbbVie worth $197K as of Q3 2026.
  • IAG Wealth Partners bought 3 AbbVie shares in Q3 2026, an estimated $769.
  • AbbVie made up 0.02% of IAG Wealth Partners's portfolio in Q3 2026, its #130 holding.
  • IAG Wealth Partners first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
  • IAG Wealth Partners's AbbVie position peaked at $251K in Q3 2024.
  • 2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on IAG Wealth Partners's 13F filing for Q3 2026, filed 6 Nov 2026.